Der Chirurg

, Volume 89, Issue 7, pp 563–574 | Cite as

Therapie des Chylothorax

  • M. Schirren
  • S. Sponholz
  • J. SchirrenEmail author


Der Chylothorax ist eine seltene, aber wichtige Form des Pleuraergusses. Er ist in der Regel postoperativen oder neoplastischen Ursprungs. Zur Behandlung des Chylothorax existieren keine prospektiven oder randomisierten Studien. Basismaßnahmen beim Chylothorax beinhalten die Drainage des Ergusses sowie diätetische Maßnahmen. Vorrangig wird der Chylothorax konservativ therapiert. Beim Versagen der konservativen Therapiemaßnahmen kommen interventionell-radiologische und chirurgische Prozeduren zur Anwendung. Der Chylothorax hat eine hohe Morbidität und Mortalität.


Differenzialdiagnosen Chylöser Erguss Ductus thoracicus Chirurgische Komplikation Duktusligatur 

Treatment of chylothorax


Chylothorax is an infrequent but important form of pleural effusion. The most common causes are of postoperative and neoplastic origin. No prospective or randomized trials have been performed to evaluate the available treatment options for chylothorax. The basic principles of conservative treatment include drainage of the effusion and dietary measures. Chylothorax is typically treated conservatively. In the case of failure of conservative treatment, interventional radiological or surgical procedures are applied. Untreated chylothorax has a high morbidity and mortality.


Differential diagnosis Chylous effusion Thoracic duct Surgery complications Duct ligation 


Einhaltung ethischer Richtlinien


M. Schirren, S. Sponholz und J. Schirren geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.


  1. 1.
    Brinkmann S, Schroeder W, Junggeburth K et al (2016) Incidence and management of chylothorax after Ivor Lewis esophagectomy for cancer of the esophagus. J Thorac Cardiovasc Surg 151:1398–1404CrossRefPubMedGoogle Scholar
  2. 2.
    Kranzfelder M, Gertler R, Hapfelmeier A et al (2013) Chylothorax after esophagectomy for cancer: impact of the surgical approach and neoadjuvant treatment: systematic review and institutional analysis. Surg Endosc 27:3530–3538CrossRefPubMedGoogle Scholar
  3. 3.
    Bryant AS, Minnich DJ, Wei B, Cerfolio RJ (2014) The incidence and management of postoperative chylothorax after pulmonary resection and thoracic mediastinal lymph node dissection. Ann Thorac Surg 98:232–237CrossRefPubMedGoogle Scholar
  4. 4.
    Schirren J, Richter W, Schneider P, Vogt-Moykopf I (1996) Principles and results of systematic lymph node dissection in surgically treated bronchial carcinoma. Chirurg 67:869–876CrossRefPubMedGoogle Scholar
  5. 5.
    Bölükbas S, Kudelin N, Dönges T, Schirren J (2010) Therapiemanagement des Chylothorax. Chirurg 81:255–266CrossRefPubMedGoogle Scholar
  6. 6.
    Hsu MC, Itkin M (2016) Lymphatic anatomy. Tech Vasc Interv Radiol 19:247–254CrossRefPubMedGoogle Scholar
  7. 7.
    Davis HK (1915) A statistical study of the thoracic duct in man. Am J Anat 17:211–244CrossRefGoogle Scholar
  8. 8.
    Heberer et al (1991) Praxis der Chirurgie: Lunge und Mediastinum, 2. Aufl. Springer, Berlin, HeidelbergCrossRefGoogle Scholar
  9. 9.
    Langford RJ, Daudia AT, Malins TJ (1999) A morphological study of the thoracic duct at the jugulo-subclavian junction. J Cranio Maxillofac Surg 27:100–104CrossRefGoogle Scholar
  10. 10.
    Bessone LN, Ferguson TB, Burford TH (1971) Chylothorax. Ann Thorac Surg 12:527–550CrossRefPubMedGoogle Scholar
  11. 11.
    Fortin D (2008) The thoracic duct and chylothorax. In: Deslauriers J, Meyerson SL, Patterson A, Cooper JD (Hrsg) Pearson’s thoracic and esophageal surgery, 3. Aufl. Churchill Livingstone, Elsevier, Philadelphia, S 1108–1120CrossRefGoogle Scholar
  12. 12.
    Huggins JT (2010) Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med 31:743–750CrossRefPubMedGoogle Scholar
  13. 13.
    Breaux JR, Marks C (1988) Chylothorax causing reversible T‑cell depletion. J Trauma 28:705–707CrossRefPubMedGoogle Scholar
  14. 14.
    Hoskote SS, Yadav H, Jagtap P et al (2017) Chylothorax as a risk factor for thrombosis in adults: a proof-of-concept study. Ann Thorac Surg 105(4):1065. CrossRefGoogle Scholar
  15. 15.
    Shah R, Luketich J, Schuchert M et al (2013) Postesophagectomy chylothorax: Incidence, risk factors and outcomes. Ann Thorac Surg 93:897–904CrossRefGoogle Scholar
  16. 16.
    Shen Y, Feng M, Khan MA et al (2014) A simple method minimizes chylothorax after minimally invasive esophagectomy. J Am Coll Surg. PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Choh CTP, Khan OA, Rychlik IJ, McManus K (2012) Does ligation of the thoracic duct during oesophagectomy reduce the incidence of post-operative chylothorax? Int J Surg 10:203–205CrossRefPubMedGoogle Scholar
  18. 18.
    Lai FC, Chen L, Tu YR et al (2011) Prevention of chylothorax complicating extensive esophageal resection by mass ligation of thoracic duct: a random control study. Ann Thorac Surg 91:1770–1774CrossRefPubMedGoogle Scholar
  19. 19.
    Robinson CLN (1985) The management of chylothorax. Ann Thorac Surg 39:90–95CrossRefPubMedGoogle Scholar
  20. 20.
    Cannizzaro V, Frey B, Bernetbuettiker V (2006) The role of somatostatin in the treatment of persistent chylothorax in children. Eur J Cardio Thorac Surg 30:49–53CrossRefGoogle Scholar
  21. 21.
    Kelly RF, Shumway SJ (2000) Conservative management of postoperative chylothorax using somatostatin. Ann Thorac Surg 69:1944–1945CrossRefPubMedGoogle Scholar
  22. 22.
    Mares DC, Mathur PN (1998) Medical thoracoscopic talc pleurodesis for chylothorax due to lymphoma* a case series. Chest 114:731–735CrossRefPubMedGoogle Scholar
  23. 23.
    Cho HJ, Kim DK, Lee GD et al (2014) Chylothorax complicating pulmonary resection for lung cancer: effective management and pleurodesis. Ann Thorac Surg 97:408–413CrossRefPubMedGoogle Scholar
  24. 24.
    Alejandre-Lafont E, Krompiec C, Rau WS, Krombach GA (2011) Effectiveness of therapeutic lymphography on lymphatic leakage. Acta Radiol 52:305–311CrossRefPubMedGoogle Scholar
  25. 25.
    Boffa DJ, Sands MJ, Rice TW et al (2008) A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery. Eur J Cardiothorac Surg 33:435–439CrossRefPubMedGoogle Scholar
  26. 26.
    Cope C, Kaiser LR (2002) Management of unremitting chylothorax by percutaneous embolization and blockage of retroperitoneal lymphatic vessels in 42 patients. J Vasc Interv Radiol 13:1139–1148CrossRefPubMedGoogle Scholar
  27. 27.
    Sziklavari Z, Allgäuer M, Hübner G et al (2013) Radiotherapy in the treatment of postoperative chylothorax. J Cardiothorac Surg 8:72CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Cerfolio RJ, Allen MS, Deschamps C et al (1996) Postoperative chylothorax. J Thorac Cardiovasc Surg 112:1361–1366CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Klinik für Thoraxchirurgie, AGAPLESION Markus Krankenhaus Frankfurt am MainAkademisches Lehrkrankenhaus der Goethe-Universität Frankfurt am MainFrankfurt am MainDeutschland

Personalised recommendations